Does TRALOKINUMAB-LDRM Cause Injection site swelling? 119 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Injection site swelling have been filed in association with TRALOKINUMAB-LDRM. This represents 2.9% of all adverse event reports for TRALOKINUMAB-LDRM.
119
Reports of Injection site swelling with TRALOKINUMAB-LDRM
2.9%
of all TRALOKINUMAB-LDRM reports
0
Deaths
3
Hospitalizations
How Dangerous Is Injection site swelling From TRALOKINUMAB-LDRM?
Of the 119 reports, 3 (2.5%) required hospitalization.
Is Injection site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRALOKINUMAB-LDRM. However, 119 reports have been filed with the FAERS database.
What Other Side Effects Does TRALOKINUMAB-LDRM Cause?
Dermatitis atopic (613)
Drug ineffective (461)
Pruritus (365)
Rash (266)
Injection site pain (206)
Injection site erythema (136)
Dry skin (135)
Erythema (133)
Eczema (129)
Injection site pruritus (124)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which TRALOKINUMAB-LDRM Alternatives Have Lower Injection site swelling Risk?
TRALOKINUMAB-LDRM vs TRAMADOL
TRALOKINUMAB-LDRM vs TRAMADOL\TRAMADOL
TRALOKINUMAB-LDRM vs TRAMETINIB
TRALOKINUMAB-LDRM vs TRAMETINIB DIMETHYL SULFOXIDE
TRALOKINUMAB-LDRM vs TRANDOLAPRIL